Psychiatry and Neurology, Neurology · Silver Spring, MD
NPI
1730151986
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
3801 International Dr, Suite 210
Silver Spring, MD, 20906
Phone (301) 562-7200
Groups this clinician bills Medicare through
Medicare paid, 2024
$291K
2,448 services
Medicare patients, 2024
928
Average age 78
Drug cost, 2024
$461K
2,768 prescriptions
Company payments, 2025
$2,812
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David L Taragin was code 99214 (office e&m - established), 1,018 times for 621 patients. In total David L Taragin billed 2,448 services in 19 codes, and Medicare paid $291K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,018 | 621 | $101.64 | $103K |
| 95886 Electrical Nerve Conductivity | Office | 387 | 191 | $83.66 | $32K |
| 99204 Office E&M - New | Office | 345 | 345 | $133.04 | $46K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 266 | 235 | $14.23 | $3,785 |
| 95819 Neurologic | Office | 153 | 152 | $410.80 | $63K |
| 95910 Electrical Nerve Conductivity | Office | 138 | 137 | $140.93 | $19K |
| 99215 Office E&M - Established | Office | 41 | 41 | $153.71 | $6,302 |
| 95911 Electrical Nerve Conductivity | Office | 36 | 36 | $187.70 | $6,757 |
| 95912 Electrical Nerve Conductivity | Office | 16 | 16 | $200.92 | $3,215 |
| 99205 Office E&M - New | Office | 16 | 16 | $154.83 | $2,477 |
By year: 2022 $294K for 2,297 services; 2023 $302K for 2,235 services; 2024 $291K for 2,448 services.
Medicare prescription drug claims, 2024
In 2024, the drug David L Taragin prescribed most often to Medicare patients was Donepezil Hcl, with 517 prescriptions and refills. In total David L Taragin wrote 2,768 Medicare prescriptions that cost $461K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 517 | 1,266 | 160 | $7,651 |
| Nortriptyline Hcl Generic | 298 | 675 | 123 | $7,791 |
| Primidone Generic | 196 | 504 | 60 | $5,526 |
| Gabapentin Generic | 176 | 427 | 70 | $5,499 |
| Memantine Hcl Er Memantine Hcl | 143 | 337 | 39 | $20K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 119 | 255 | 36 | $5,855 |
| Quetiapine Fumarate Generic | 119 | 231 | 33 | $2,358 |
| Levetiracetam Generic | 94 | 224 | 25 | $4,109 |
| Escitalopram Oxalate Generic | 82 | 234 | 31 | $1,791 |
| Memantine Hcl Generic | 79 | 202 | 35 | $4,643 |
| Topiramate Generic | 57 | 171 | 15 | $989 |
| Pyridostigmine Bromide Generic | 51 | 112 | 15 | $3,283 |
| Clonazepam Generic | 51 | 117 | 19 | $772 |
| Ropinirole Hcl Generic | 46 | 99 | 13 | $1,369 |
| Duloxetine Hcl Generic | 31 | 61 | Under 11 | $1,105 |
Brand drugs: - claims; generic drugs: 2,639 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David L Taragin $2,812 ($2,812 in general payments such as food, travel and fees) from 32 companies. The largest payer was Lundbeck LLC with $500.
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 37 | $500 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $243 |
| Genentech USA, Inc. ROG.SW | 13 | $239 |
| Biogen, Inc. BIIB | 12 | $203 |
| Eisai Inc. 4523.T | 13 | $195 |
| Pfizer Inc. PFE | 13 | $165 |
| EMD Serono, Inc. MRK.DE | 7 | $154 |
| Amneal Pharmaceuticals LLC AMRX | 4 | $95.07 |
| Neurelis, Inc. | 4 | $94.38 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $82.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.